title: [The diagnostic information value of determining tumor-associated antigen Ca-19-9 in pancreatic cancer].
abstract: Clinical utility of radioimmunologic assessment of blood tumor-associated CA-19-9 antigen level was evaluated in 225 cases of various biliopancreatoduodenal pathology. The levels exceeded the discriminating value of 40 U/ml in 96.4% of patients with pancreatic cancer (mean - 641.7 U/ml), specifically, in those radically operated on for tumors 3 cm in diameter or larger. Application of this noninvasive method for screening for resectable pancreatic carcinoma is justified.
authors.forename: V M
authors.initials: VM
authors.lastname: Samoĭlenko
authors.forename: M N
authors.initials: MN
authors.lastname: Afrikian
authors.forename: A B
authors.initials: AB
authors.lastname: Itin
mesh_terms: D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D003937:Diagnosis, Differential; D005069:Evaluation Studies as Topic; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis*; D011863:Radioimmunoassay; D011933:Reagent Kits, Diagnostic
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D011933:Reagent Kits, Diagnostic
vernacular_title: Diagnosticheskaia informativnost' opredeleniia opukholeassotsiirovannogo antigena Ca-19-9 pri rake podzheludochnoĭ zhelezy.